Etoposide
Etoposide is indicated for the management of:
- testicular tumours in combination with other chemotherapeutic agents
- small cell lung cancer, in combination with other chemotherapeutic agents
- monoblastic leukaemia (AML M5) and acute myelomonoblastic leukaemia (AML M4) when standard therapy has failed (in combination with other chemotherapeutic agents).